South Korea
· Delayed Price · Currency is KRW Choong Ang Vaccine Laboratory Statistics
Total Valuation
Choong Ang Vaccine Laboratory has a market cap or net worth of KRW 96.45 billion.
| Market Cap | 96.45B |
| Enterprise Value | n/a |
Important Dates
The next estimated earnings date is Tuesday, November 26, 2024.
| Earnings Date | Nov 26, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Choong Ang Vaccine Laboratory has 9.56 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 9.56M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.73% |
| Owned by Insiders (%) | 34.86% |
| Owned by Institutions (%) | 0.49% |
| Float | 6.23M |
Valuation Ratios
The trailing PE ratio is 26.90.
| PE Ratio | 26.90 |
| Forward PE | n/a |
| PS Ratio | 2.50 |
| PB Ratio | 1.01 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 69.53 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.11, with a Debt / Equity ratio of 0.12.
| Current Ratio | 3.11 |
| Quick Ratio | 1.71 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 1.11 |
| Debt / FCF | 8.04 |
| Interest Coverage | 14.69 |
Financial Efficiency
Return on equity (ROE) is 3.83% and return on invested capital (ROIC) is 2.34%.
| Return on Equity (ROE) | 3.83% |
| Return on Assets (ROA) | 2.18% |
| Return on Capital (ROIC) | 2.34% |
| Revenue Per Employee | 234.67M |
| Profits Per Employee | 21.85M |
| Employee Count | 167 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 1.21 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.66% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -5.66% |
| 50-Day Moving Average | 10,372.60 |
| 200-Day Moving Average | 10,597.95 |
| Relative Strength Index (RSI) | 40.84 |
| Average Volume (20 Days) | 53,843 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Choong Ang Vaccine Laboratory had revenue of KRW 39.19 billion and earned 3.65 billion in profits. Earnings per share was 375.11.
| Revenue | 39.19B |
| Gross Profit | 18.66B |
| Operating Income | 3.99B |
| Pretax Income | 4.65B |
| Net Income | 3.65B |
| EBITDA | 10.01B |
| EBIT | 3.99B |
| Earnings Per Share (EPS) | 375.11 |
Balance Sheet
The company has 18.14 billion in cash and 11.15 billion in debt, giving a net cash position of 6.99 billion or 731.28 per share.
| Cash & Cash Equivalents | 18.14B |
| Total Debt | 11.15B |
| Net Cash | 6.99B |
| Net Cash Per Share | 731.28 |
| Equity (Book Value) | 96.09B |
| Book Value Per Share | 9,948.04 |
| Working Capital | 28.25B |
Cash Flow
In the last 12 months, operating cash flow was 6.41 billion and capital expenditures -5.02 billion, giving a free cash flow of 1.39 billion.
| Operating Cash Flow | 6.41B |
| Capital Expenditures | -5.02B |
| Free Cash Flow | 1.39B |
| FCF Per Share | 145.12 |
Margins
Gross margin is 47.62%, with operating and profit margins of 10.18% and 9.31%.
| Gross Margin | 47.62% |
| Operating Margin | 10.18% |
| Pretax Margin | 11.86% |
| Profit Margin | 9.31% |
| EBITDA Margin | 25.53% |
| EBIT Margin | 10.18% |
| FCF Margin | 3.54% |
Dividends & Yields
This stock pays an annual dividend of 150.00, which amounts to a dividend yield of 1.50%.
| Dividend Per Share | 150.00 |
| Dividend Yield | 1.50% |
| Dividend Growth (YoY) | 50.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 26.75% |
| Buyback Yield | 0.94% |
| Shareholder Yield | 2.44% |
| Earnings Yield | 3.72% |
| FCF Yield | 1.44% |
Stock Splits
The last stock split was on July 18, 2018. It was a forward split with a ratio of 1.2.
| Last Split Date | Jul 18, 2018 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
Choong Ang Vaccine Laboratory has an Altman Z-Score of 5.35.
| Altman Z-Score | 5.35 |
| Piotroski F-Score | n/a |